Riese Richard J. 4
4 · SYNLOGIC, INC. · Filed Jan 2, 2020
Insider Transaction Report
Form 4
SYNLOGIC, INC.SYBX
Riese Richard J.
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2019-12-31+150,000→ 150,000 totalExercise: $2.58Exp: 2029-12-31→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The option will vest and become exercisable as to one-fourth (1/4) of the shares on September 16, 2020, and the remainder will vest and become exercisable at one-forty-eighth (1/48th) of the shares per month thereafter, subject to the Reporting Person continuing to provide services to the Issuer as Chief Medical Officer through each such vesting date.